Cultures for acid-fast bacilli: are we being good stewards?

Abstract Objective: To describe the use of cultures for acid-fast bacilli (AFB) and situations in which AFB cultures are unlikely to be of clinical benefit. Design: Retrospective descriptive study of AFB cultures submitted to Sentara Health microbiology laboratory from December 1, 2021, to Decem...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Hanrahan, Julie D. Sill, Patricia Ver Schneider, Jessica F. Copeland, Elsie Frimpongmaa Amoako-Kissi, Ogochukwu O. Ilobi, Angela J. Toepp
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X24004637/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526431773884416
author Jennifer Hanrahan
Julie D. Sill
Patricia Ver Schneider
Jessica F. Copeland
Elsie Frimpongmaa Amoako-Kissi
Ogochukwu O. Ilobi
Angela J. Toepp
author_facet Jennifer Hanrahan
Julie D. Sill
Patricia Ver Schneider
Jessica F. Copeland
Elsie Frimpongmaa Amoako-Kissi
Ogochukwu O. Ilobi
Angela J. Toepp
author_sort Jennifer Hanrahan
collection DOAJ
description Abstract Objective: To describe the use of cultures for acid-fast bacilli (AFB) and situations in which AFB cultures are unlikely to be of clinical benefit. Design: Retrospective descriptive study of AFB cultures submitted to Sentara Health microbiology laboratory from December 1, 2021, to December 1, 2023. Data were collected from the electronic medical record and included patient demographics, the service line that ordered the culture, specimen source, and culture results. Setting: Sentara Healthcare System. Patients: All patients who had specimens submitted to the microbiology laboratory during the study period were included. Results: A total of 13,944 AFB cultures from 8,243 patients were collected during the study period. Of these, 4.72% (n = 389) patients had a positive result, and 40 of 680 positive cultures were likely contaminants or non-mycobacterial. The average number of days between culture collection and positive results was 84.32 days (SD = 49.64) and 56.25 days (SD = 8.32) for negative results. Most cultures were ordered by medical subspecialties (44.06%, n = 6,144), followed by orthopedic providers (23.34%, n = 3,254) and surgical subspecialty providers (16.11%, n = 2,246). Most specimens were pulmonary (n = 6,620) with 619 (9.35%) positive cultures. Of 3,561 AFB cultures ordered from bone specimens, only 17 were positive (0.48%). The number of specimens processed by the microbiology laboratory required 2 full-time microbiology technicians to process specimens. Conclusions: Many AFB cultures were sent from patients who did not have clinical scenarios consistent with mycobacterial disease and cultures were not clinically indicated. Implementation of testing criteria could decrease AFB cultures and healthcare costs.
format Article
id doaj-art-7a6ca8401eb743c09f9235118c6c1ced
institution Kabale University
issn 2732-494X
language English
publishDate 2025-01-01
publisher Cambridge University Press
record_format Article
series Antimicrobial Stewardship & Healthcare Epidemiology
spelling doaj-art-7a6ca8401eb743c09f9235118c6c1ced2025-01-16T21:50:44ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2025-01-01410.1017/ash.2024.463Cultures for acid-fast bacilli: are we being good stewards?Jennifer Hanrahan0https://orcid.org/0000-0002-7443-5985Julie D. Sill1Patricia Ver Schneider2Jessica F. Copeland3Elsie Frimpongmaa Amoako-Kissi4Ogochukwu O. Ilobi5Angela J. Toepp6https://orcid.org/0000-0002-0432-5780Macon and Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USAMacon and Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USASentara Health, Enterprise Analytics, Virginia Beach, VA, USASentara Health, Enterprise Analytics, Virginia Beach, VA, USAMacon and Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USAMacon and Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USAMacon and Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USA Sentara Health, Enterprise Analytics, Virginia Beach, VA, USA Abstract Objective: To describe the use of cultures for acid-fast bacilli (AFB) and situations in which AFB cultures are unlikely to be of clinical benefit. Design: Retrospective descriptive study of AFB cultures submitted to Sentara Health microbiology laboratory from December 1, 2021, to December 1, 2023. Data were collected from the electronic medical record and included patient demographics, the service line that ordered the culture, specimen source, and culture results. Setting: Sentara Healthcare System. Patients: All patients who had specimens submitted to the microbiology laboratory during the study period were included. Results: A total of 13,944 AFB cultures from 8,243 patients were collected during the study period. Of these, 4.72% (n = 389) patients had a positive result, and 40 of 680 positive cultures were likely contaminants or non-mycobacterial. The average number of days between culture collection and positive results was 84.32 days (SD = 49.64) and 56.25 days (SD = 8.32) for negative results. Most cultures were ordered by medical subspecialties (44.06%, n = 6,144), followed by orthopedic providers (23.34%, n = 3,254) and surgical subspecialty providers (16.11%, n = 2,246). Most specimens were pulmonary (n = 6,620) with 619 (9.35%) positive cultures. Of 3,561 AFB cultures ordered from bone specimens, only 17 were positive (0.48%). The number of specimens processed by the microbiology laboratory required 2 full-time microbiology technicians to process specimens. Conclusions: Many AFB cultures were sent from patients who did not have clinical scenarios consistent with mycobacterial disease and cultures were not clinically indicated. Implementation of testing criteria could decrease AFB cultures and healthcare costs. https://www.cambridge.org/core/product/identifier/S2732494X24004637/type/journal_article
spellingShingle Jennifer Hanrahan
Julie D. Sill
Patricia Ver Schneider
Jessica F. Copeland
Elsie Frimpongmaa Amoako-Kissi
Ogochukwu O. Ilobi
Angela J. Toepp
Cultures for acid-fast bacilli: are we being good stewards?
Antimicrobial Stewardship & Healthcare Epidemiology
title Cultures for acid-fast bacilli: are we being good stewards?
title_full Cultures for acid-fast bacilli: are we being good stewards?
title_fullStr Cultures for acid-fast bacilli: are we being good stewards?
title_full_unstemmed Cultures for acid-fast bacilli: are we being good stewards?
title_short Cultures for acid-fast bacilli: are we being good stewards?
title_sort cultures for acid fast bacilli are we being good stewards
url https://www.cambridge.org/core/product/identifier/S2732494X24004637/type/journal_article
work_keys_str_mv AT jenniferhanrahan culturesforacidfastbacilliarewebeinggoodstewards
AT juliedsill culturesforacidfastbacilliarewebeinggoodstewards
AT patriciaverschneider culturesforacidfastbacilliarewebeinggoodstewards
AT jessicafcopeland culturesforacidfastbacilliarewebeinggoodstewards
AT elsiefrimpongmaaamoakokissi culturesforacidfastbacilliarewebeinggoodstewards
AT ogochukwuoilobi culturesforacidfastbacilliarewebeinggoodstewards
AT angelajtoepp culturesforacidfastbacilliarewebeinggoodstewards